Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
422
-
Total 13F shares, excl. options
-
56.9M
-
Shares change
-
-210K
-
Total reported value, excl. options
-
$7.41B
-
Value change
-
-$120M
-
Put/Call ratio
-
1.18
-
Number of buys
-
183
-
Number of sells
-
-263
-
Price
-
$130.21
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2021
544 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2021.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 422 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.9M shares
.
Largest 10 shareholders include BlackRock Inc. (6.26M shares), VANGUARD GROUP INC (5.48M shares), FMR LLC (3.12M shares), JPMORGAN CHASE & CO (2.9M shares), STATE STREET CORP (2.33M shares), WELLINGTON MANAGEMENT GROUP LLP (2.16M shares), RENAISSANCE TECHNOLOGIES LLC (2M shares), Polaris Capital Management, LLC (1.96M shares), LSV ASSET MANAGEMENT (1.88M shares), and CANADA PENSION PLAN INVESTMENT BOARD (1.17M shares).
This table shows the top 422 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.